A 3D pancreatic tumor model to study T cell infiltration
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
3D PDAC-TME model to observe and quantify T cell infiltration across the vasculature. In a three-channel microfluidic device, PDAC cells are cultured in a collagen matrix in the central channel surrounded, on one side, by endothelial cells (ECs) to mimic a blood vessel and, on the opposite side, by pancreatic stellate cells (PSCs) to simulate exocrine pancreas. The migration of T cells toward the tumor is quantified based on their activation state and TME composition. The presence of EC-lining drastically reduces T cell infiltration, confirming the essential role of the vasculature in controlling T cell trafficking. We show that activated T cells migrate ∼50% more than the not-activated ones toward the cancer cells. Correspondingly, in the absence of cancer cells, both activated and not-activated T cells present similar migration toward the PSCs. The proposed approach could help researchers in testing and optimizing immunotherapies for pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In contrast, co-culturing PDAC cells with PSCs markedly increased T cell infiltration, emphasizing the influence of the TME on immune cell behavior.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“| PDAC | Mollica et al. (2021) | Microfluidic device with 2 lateral channels and central chamber | ECs, PSCs, Panc-1 PDAC cells, and T cells | EC barrier decreases T cell infiltration into PSCs + Panc-1 |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al. (2021)
The cited source says what the claim attributes to it.
In the citing paper
“This innovative model employs a three-channel microfluidic device wherein PDAC cells are cultured in a central collagen matrix, bordered by ECs mimicking blood vessels on one side and pancreatic stellate cells (PSCs) simulating the exocrine pancreas on the other.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“The model facilitated the observation and quantification of T cell infiltration across the vasculature, offering insights into how TME composition influences T cell migration.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“To investigate T cell infiltration, an integral aspect of anti-tumor immune responses in PDAC, researchers developed a 3D in vitro PDAC-TME model (Mollica et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Smith-Garvin, J. E., Koretzky, G. A., & Jordan, M. S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132706 · Cited by 2,144
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubat, T., Yagita, H., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.765 · Cited by 1,589
Ghaffari, S., Chandorkar, S. A., Wang, S., Ng, E. J., Ahn, C. H., Hong, V., Yang, Y., & Kenny, T. W. (2014) · Scientific Reports · doi:10.1038/srep04331 · Cited by 1,521
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Clark, C. E., Hingorani, S. R., Mick, R., Combs, C., Tuveson, D. A., & Vonderheide, R. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0175 · Cited by 990
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
The Impact of Food Bioactives on Health
(2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4 · Cited by 805
Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels
Shin, Y., Han, S., Jeon, J. S., Yamamoto, K., Zervantonakis, I. K., Sudo, R., Kamm, R. D., & Chung, S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.051 · Cited by 617
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Adamska, A., Domenichini, A., & Falasca, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071338 · Cited by 610
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Von Hoff, D. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 601
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Ibáñez-Sanz, G., Díez-Villanueva, A., Alonso, M. H., Rodríguez-Moranta, F., Pérez-Gómez, B., Bustamante, M., Martin, V., Llorca, J., Amiano, P., Ardanaz, E., et al. (2017) · Scientific Reports · doi:10.1038/srep46807 · Cited by 505
An evolving new paradigm: endothelial cells – conditional innate immune cells
Mai, J., Virtue, A., Shen, J., Wang, H., & Yang, X.-F. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-61 · Cited by 433
T cell migration, search strategies and mechanisms
Krummel, M. F., Bartumeus, F., & Gérard, A. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.16 · Cited by 423
Tsai, S., McOlash, L., Palen, K., Johnson, B., Duris, C., Yang, Q., Dwinell, M. B., Hunt, B., Evans, D. B., Gershan, J., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4238-4 · Cited by 400
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
Simon, S., & Labarriere, N. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1364828 · Cited by 394
Dynamic flood modeling essential to assess the coastal impacts of climate change
Barnard, P. L., Erikson, L. H., Foxgrover, A. C., Hart, J. A. F., Limber, P., O’Neill, A. C., van Ormondt, M., Vitousek, S., Wood, N., Hayden, M. K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40742-z · Cited by 375
T cell stimulation and expansion using anti-CD3/CD28 beads
Trickett, A., & Kwan, Y. L. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00010-3 · Cited by 367
Dirkx, A. E. M., Egbrink, M. G. A. O., Kuijpers, M. J. E., van der Niet, S. T., Heijnen, V. V. T., Steege, J. C. A. B.-T., Wagstaff, J., & Griffioen, A. W. (2003) · PubMed · Cited by 325
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
Pereira, B. A., Vennin, C., Papanicolaou, M., Chambers, C. R., Herrmann, D., Morton, J. P., Cox, T. R., & Timpson, P. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.09.010 · Cited by 314
Penny, H. L., Sieow, J. L., Adriani, G., Yeap, W. H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S. Y., Ho, Y. S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1191731 · Cited by 254
Self-citationA 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
Pavesi, A., Tan, A. T., Koh, S., Chia, A., Colombo, M., Antonecchia, E., Miccolis, C., Ceccarello, E., Adriani, G., Raimondi, M. T., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89762 · Cited by 241
Self-citationLi, Y., & Kurlander, R. J. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-104 · Cited by 207
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Klein, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00367 · Cited by 196
Oppenheimer-Marks, N., Davis, L. S., & Lipsky, P. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.140 · Cited by 192
Permeability characteristics of cultured endothelial cell monolayers
Albelda, S. M., Sampson, P. M., Haselton, F. R., McNiff, J. M., Mueller, S. N., Williams, S. K., Fishman, A. P., & Levine, E. M. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.64.1.308 · Cited by 182
Parlato, S., De Ninno, A., Molfetta, R., Toschi, E., Salerno, D., Mencattini, A., Romagnoli, G., Fragale, A., Roccazzello, L., Buoncervello, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01013-x · Cited by 181
Targeting Pancreatic Stellate Cells in Cancer
Schnittert, J., Bansal, R., & Prakash, J. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.01.001 · Cited by 159
Wells, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803917 · Cited by 153
Aung, A., Kumar, V., Theprungsirikul, J., Davey, S. K., & Varghese, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0342 · Cited by 146
Fu, Y., Liu, S., Zeng, S., & Shen, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0815-z · Cited by 138
Cannon, A. C., Thompson, C. M., Hall, B. R., Jain, M., Sushil Kumar, K., & Batra, S. K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.171 · Cited by 135
Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity.
Brezinschek, R. I., Lipsky, P. E., Galea, P., Vita, R., & Oppenheimer-Marks, N. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3062 · Cited by 126
Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
Wilson, J. S., Pirola, R. C., & Apte, M. V. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00052 · Cited by 120
3D approaches to model the tumor microenvironment of pancreatic cancer
Tomás-Bort, E., Kieler, M., Sharma, S., Candido, J. B., & Loessner, D. (2020) · Theranostics · doi:10.7150/thno.42441 · Cited by 114
Bai, J., Adriani, G., Dang, T.-M., Tu, T.-Y., Leong Penny, H.-X., Wong, S.-C., Kamm, R. D., & Thiery, J.-P. (2015) · Oncotarget · doi:10.18632/oncotarget.4716 · Cited by 110
Self-citationCharacterizing the role of monocytes in T cell cancer immunotherapy using a 3d microfluidic model
Lee, S. W. L., Adriani, G., Ceccarello, E., Pavesi, A., Tan, A. T., Bertoletti, A., Kamm, R. D., & Wong, S. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00416 · Cited by 109
Self-citationExperimental models of pancreatic cancer desmoplasia
Suklabaidya, S., Dash, P., Das, B., Suresh, V., Sasmal, P. K., & Senapati, S. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.127 · Cited by 71
Microfluidic models for adoptive cell-mediated cancer immunotherapies
Adriani, G., Pavesi, A., Tan, A. T., Bertoletti, A., Thiery, J. P., & Kamm, R. D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.006 · Cited by 66
Self-citation3D Immunocompetent Organ‐on‐a‐Chip Models
Maharjan, S., Cecen, B., & Zhang, Y. S. (2020) · Small Methods · doi:10.1002/smtd.202000235 · Cited by 62
Sakellariou-Thompson, D., Forget, M.-A., Creasy, C., Bernard, V., Zhao, L., Kim, Y. U., Hurd, M. W., Uraoka, N., Parra, E. R., Kang, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0831 · Cited by 60
Lee, S. W. L., Seager, R. J., Litvak, F., Spill, F., Sieow, J. L., Leong, P. H., Kumar, D., Tan, A. S. M., Wong, S. C., Adriani, G., et al. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa007 · Cited by 60
Self-citationTumor blood vessels, a difficult hurdle for infiltrating leukocytes
Castermans, K., & Griffioen, A. W. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.005 · Cited by 57
Review: Bioengineering strategies to probe T cell mechanobiology
de la Zerda, A., Kratochvil, M. J., Suhar, N. A., & Heilshorn, S. C. (2018) · APL Bioengineering · doi:10.1063/1.5006599 · Cited by 57
Molecular Pathways: Myeloid Complicity in Cancer
Stromnes, I. M., Greenberg, P. D., & Hingorani, S. R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0866 · Cited by 52
Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis
Qiu, W., & Su, G. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9408-2 · Cited by 50
Hwang, H. K., Kim, H., Kim, S. H., Choi, J., Kang, C. M., Kim, K. S., & Lee, W. J. (2016) · Oncology Letters · doi:10.3892/ol.2016.5252 · Cited by 49
Mascolo, D. D., Varesano, S., Benelli, R., Mollica, H., Salis, A., Zocchi, M. R., Decuzzi, P., & Poggi, A. D. (2019) · Cancers · doi:10.3390/cancers12010104 · Cited by 40
Self-citationMiermont, A., Lee, S. W. L., Adriani, G., & Kamm, R. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-50198-w · Cited by 39
Self-citationBersini, S., Miermont, A., Pavesi, A., Kamm, R. D., Thiery, J. P., Moretti, M., & Adriani, G. (2018) · Oncotarget · doi:10.18632/oncotarget.26306 · Cited by 38
Self-citationMiller, J. D., Clabaugh, S. E., Smith, D. R., Stevens, R. B., & Wrenshall, L. E. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.45 · Cited by 37
Two-Channel Compartmentalized Microfluidic Chip for Real-Time Monitoring of the Metastatic Cascade
Mollica, H., Palomba, R., Primavera, R., & Decuzzi, P. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00697 · Cited by 36
Self-citationUpcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma
Swayden, M., Soubeyran, P., & Iovanna, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01443 · Cited by 31
Mercurio, A., Sharples, L., Corbo, F., Franchini, C., Vacca, A., Catalano, A. A., Carocci, A., Kamm, R. D., Pavesi, A., & Adriani, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00349 · Cited by 28
Self-citationBrunet, L. R., Hagemann, T., Gaya, A. M., Mudan, S., & Marabelle, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1112942 · Cited by 27
Mollica, H., Coclite, A., Miali, M. E., Pereira, R. C., Paleari, L., Manneschi, C., DeCensi, A., & Decuzzi, P. (2018) · Biomicrofluidics · doi:10.1063/1.5022879 · Cited by 22
Self-citationModels for Monocytic Cells in the Tumor Microenvironment
Lee, S. W. L., Adriani, G., Kamm, R. D., & Gillrie, M. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35723-8_7 · Cited by 12
Self-citation
Research works printed but not linked: 4
- M. M. Boyiadzis, J. M. Kirkwood, J. L. Marshall, C. C. Pritchard, N. S. Azad and J. L. Gulley, J. Immunother. Cancer, 2018, 6, 1.
- A. E. Dirkx, M. G. oude Egbrink, M. J. Kuijpers, S. T. van der Niet, V. V. Heijnen, J. C. Bouma-ter Steege, J. Wagstaff and A. W. Griffioen, Cancer Res., 2003, 63, 2322.
- G. Adriani, A. Pavesi and R. D. Kamm, in Methods in Cell Biology, ed. J. Doh, D. Fletcher and M. Piel, Elsevier, 2018, vol. 146, p. 199.
- E. Agliari, E. Biselli, A. De Ninno, G. Schiavoni, L. Gabriele, A. Gerardino, F. Mattei, A. Barra and L. Businaro, Sci. Rep., 2014, 4, 1.
Cited by
Biomaterial-based platforms for tumour tissue engineering
Curvello, R., Kast, V., Ordóñez‐Morán, P., Mata, Á., & Loessner, D. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00535-3 · Cited by 87
Next generation organoid engineering to replace animals in cancer drug testing
Hockney, S., Parker, J., Turner, J. E., Todd, X., Todryk, S. M., Gieling, R. G., Hilgen, G., Simoes, D. C. M., & Pal, D. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115586 · Cited by 59
“Modelling immunotherapy in vitro requires creating an overlap between the lymphoid tissues in which immune responses develop, the cancer tissues in which the resulting immune responses need to act against the tumour cells, and the vessels that transport the immune cells between the two [104,105].”
BackgroundRavi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 47
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors
Liu, H., Noguera-Ortega, E., Dong, X., Lee, W. D., Chang, J., Aday, S., Li, Y., Shin, Y., Shi, X., Liousia, M., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02845-z · Cited by 55
“…flexibility and precise experimental control afforded by micro-fabricated cell culture devices to create specialized in vitro models, termed tumor-on-a-chip, that can more accurately emulate human solid malignancies and their local environment during CAR-T and other adoptive cell therapies 24–28 .”
Recent advances in vascularized tumor-on-a-chip
Huang, C. B. X., & Tu, T.-Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150332 · Cited by 34
“(42) investigated T-cell infiltration into the pancreatic cancer TME comprising Panc-1 cells, pancreatic stellate cells, and HUVECs, each seeded in different microfluidic channels.”
Background
Metadata
- Authors
- Mollica, H., Teo, Y. J., Tan, A. S. M., Tan, D. Z. M., Decuzzi, P., Pavesi, A., & Adriani, G.
- Affiliations
- Italian Institute of Technology (IT)
- Agency for Science, Technology and Research (SG)
- Corresponding author
- Adriani, Giulia
- ORCID
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 9
- Issue
- 22
- Pages
- 7420-7431
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W3210582147
- Cited by
- 32
- References
- 68
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 12 · 2022: 4
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biomaterials Science (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc)
- Funders
- Biomedical Research Council
- National Research Foundation Singapore (NRF2017-SISFP09)
- Agency for Science, Technology and Research
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- pancreatic ductal adenocarcinoma, T cell infiltration, tumor microenvironment, 3D tumor models, microfluidics, collagen matrix, endothelial cells, pancreatic stellate cells, T cell migration, T cell activation, vascular system
- MeSH terms
- Humans, Pancreatic Neoplasms, T-Lymphocytes, Carcinoma, Pancreatic Ductal, Endothelial Cells, Pancreatic Stellate Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.